SCHEMBL7993424

SCHEMBL7993424

Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.72
CA12 O43570 3/20 0.68
CA1 P00915 3/20 0.68
CA2 P00918 3/20 0.68
CA9 Q16790 3/20 0.68
CA4 P22748 2/20 0.68
CA6 P23280 2/20 0.68
CA5A P35218 2/20 0.68
CA7 P43166 2/20 0.68
CA13 Q8N1Q1 2/20 0.68
CA14 Q9ULX7 2/20 0.68
LMNA P02545 2/20 0.68
PPARG P37231 1/20 0.65
RAB9A P51151 1/20 0.65
RXFP1 Q9HBX9 1/20 0.65
NR2E3 Q9Y5X4 1/20 0.65
NCOR2 Q9Y618 1/20 0.65
KMT2A Q03164 4/20 0.64
MEN1 O00255 3/20 0.64
MAPT P10636 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24713415 0.93 CA12 (0.68) TP53CA12CA1CA2CA9
SCHEMBL23447443 0.90 TP53 (0.56) TP53CA12CA1CA2CA9
SCHEMBL1928662 0.88 CA12 (0.85) TP53CA12CA1CA2CA9
SCHEMBL6243996 0.88 CA12 (0.85) TP53CA12CA1CA2CA9
SCHEMBL23421176 0.88 TP53 (0.63) TP53CA12CA1CA2CA9
SCHEMBL6468377 0.87 CA12 (0.70) TP53CA12CA1CA2CA9
SCHEMBL9488026 0.86 CNR2 (0.61) TP53CA12CA1CA2CA9
SCHEMBL9486707 0.86 MEN1 (0.65) TP53CA12CA1CA2CA9
SCHEMBL9487208 0.85 HRH3 (0.61) TP53CA12CA1CA2CA9
SCHEMBL8764152 0.85 EPHX2 (0.55) TP53CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP claimed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US claimed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US claimed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP claimed
CN-114761379-A Color-developing agent and heat-sensitive recording material 三菱化学株式会社 2022-07-15 CN disclosed
WO-2021107037-A1 DEVELOPER AND THERMOSENSITIVE RECORDING MATERIAL 三菱ケミカル株式会社 2021-06-03 WO disclosed
US-6281240-B1 CYSTIC FIBROSIS ELI LILLY AND COMPANY 2001-08-28 US disclosed
WO-1998044799-A1 DIARYLSULFONYLUREAS FOR USE IN TREATING SECRETORY DIARRHEA ELI LILLY AND COMPANY (US) 1998-10-15 WO disclosed
EP-0606723-A1 Imidazolidin-2-one derivatives and their use as antitumor agents ELI LILLY AND COMPANY (US) 1994-07-20 EP disclosed
US-5270329-A 1-arylsulfonyl-imidazolidin-2-one derivatives ELI LILLY AND COMPANY (US) 1993-12-14 US disclosed
US-5260338-A Sulfonylureas ELI LILLY AND COMPANY (US) 1993-11-09 US disclosed
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP disclosed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP disclosed